An interventional study of Physical Therapy in Carpal Tunnel Syndrome, sponsored by Brooke Army Medical Center. Completed at 1 site in United States. Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2026-11-19.
Sponsored by Brooke Army Medical Center · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 97 studies in Carpal Tunnel Syndrome with a site in United States — 10 open to participants now, 12 under way, none of them phase 3. Carpal Tunnel Syndrome · United States.
Among the 97 studies in Carpal Tunnel Syndrome with a site in United States, this one is the 68th largest by enrollment of the 72 interventional ones that give a count, is one of 4 that started in 2024, is one of 47 with no phase, and was the 90th registered.
590 studies on the registry are indexed under Carpal Tunnel Syndrome; 133 are open to participants now.
Browse Carpal Tunnel Syndrome studies →10 of the 97 studies in Carpal Tunnel Syndrome with a site in United States are open now. Recruiting first, the newest first:
New York Institute of Technology · Sites in United States
Ages 18+
University of Nevada, Las Vegas · Sites in United States
Ages 18+
University of Arizona · Sites in United States
Ages 18+
University of Chicago · Sites in United States
Ages 18+
Extremity Medical · Sites in United States
Ages 18–85
A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →
Of the 72 Carpal Tunnel Syndrome studies recruiting now, 27 (38%) set no upper age limit and 36 (50%) stop at 75 or younger; 1 takes children under 18; 11 take healthy volunteers.
This study: 18 Years to 65 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
97 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 5 · Phase 2 11 · Phase 3 2 · Phase 4 10
First in 1997; this study’s year is marked. 4 started in 2024.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 6 is below the median of 60 across 446 interventional studies indexed under Carpal Tunnel Syndrome.
Median enrollment 50 across the 72 interventional studies, 107 across the 24 observational. Of the 68 that completed or were terminated, 16 (24%) have results posted.
This tab as a report to print or save as PDF → With an account.
15 of 97 have an industry lead sponsor. The 10 most frequent:
Brooke Army Medical Center is the lead sponsor of 94 studies on the registry; 10 are open to participants now.
Of its 8 completed or terminated interventional studies of FDA-regulated products, 2 (25%) have results posted.
Brooke Army Medical Center has 1 study filed under Carpal Tunnel Syndrome — fewer than ten, so there is no comparison to draw.
4 of the studies in Carpal Tunnel Syndrome with a site in United States that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT04804293Mayo ClinicAssessment of Carpal Tunnel Syndrome by Shearwave Elastography | 2026-12-20 |
| NCT07158892University of Texas at AustinUnderstanding Patient Preferences When Deciding on a Voluntary Musculoskeletal Test | 2027-01-20 |
| NCT06907849University of Tennessee Graduate School of Medicine124I-Evuzamitide PET/CT Imaging In Patients With Lumbar Spinal Stenosis and Carpal Tunnel Syndrome | 2027-03 |
| NCT04206215Spaulding Rehabilitation HospitalNoninvasive Brain Stimulation for Treating Carpal Tunnel Syndrome | 2027-07-02 |
Add all 4 to your calendar (.ics) → With an account.
Among the 97 studies in Carpal Tunnel Syndrome with a site in United States, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The diagnosis of carpal tunnel syndrome (CTS) is typically based on clinical findings and confirmatory electrodiagnostic testing. However, electrodiagnostic testing can only assess large A-alpha and A-beta nerve fibers. Quantitative sensory testing (QST) is a series of tests used to assess small nerve fiber changes in the A-delta, c-fibers, and A-beta nerve fibers as well. Previous studies have used QST to assess small nerve fiber changes related to carpal tunnel syndrome and found changes compared to controls. This study will utilize a course of standard physical therapy care and assess for any changes to small nerve fiber activity and how those changes may or may not relate to patient outcomes.
Purpose: To assess changes in A-beta, A-delta, and C-fiber function after standard physical therapy interventions in individuals with CTS.
Specific Aim 1 (primary aim): Determine if A-beta, A-delta, and C-fiber functions change following a course of Physical Therapy (PT) in individuals with CTS.
Specific Aim 2 (secondary aim): Describe the relationship between changes in QST and changes in a patient-reported outcome measure after a course of PT in individuals with a clinical diagnosis of CTS.
The criteria were revised on the registry on Nov 19, 2026. See what changed
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
DEERS eligible Age 18-65 Pain and paresthesia in the median nerve distribution A positive Phalen test A positive Tinel test over the carpal tunnel Monofilament threshold > 2.83 (0.07g) over the median nerve distribution Willing to attend physical therapy
Exclusion Criteria:
Nerve root signs consistent with a radiculopathy Suspected radial and ulnar nerve involvement based on monofilament testing Systemic conditions affecting nerve health (e.g. endocrine disorders, diabetes mellitus, rheumatoid arthritis) Previous hand surgery Injections in the upper quarter in the last 6 months Cervical, shoulder, or UE trauma in the last 6 months Currently pregnant or postpartum within the last 6 months No more than minimal care (evaluation and patient education, 1 visit) for the current episode
Age 18-65 years with unilateral carpal tunnel syndrome.
Other: Physical Therapy
The intervention will be physical therapy standard care.
Quantitative Sensory Testing (QST)
QST is a test method that measures sensory thresholds for temperature sensations, touch, vibration, and pain and is described in section 10.1. All thermal testing (CDT, WDT, CPT, and HPT) will be performed via the TSA 2 Thermosensory Stimulator.
Time frame: From enrollment until the end of the study at 12 weeks
Boston Carpal Tunnel Questionnaire (BCTQ)
The BCTQ is a self-based outcome scale measured with 2-parts, the symptom severity scale and functional status scale. Both scales are likert scales 1-5.
Time frame: From enrollment until the end of the study at 12 weeks
Numeric Pain Rating Scale (NPRS)
he NPRS is an 11-point scale ('0' indicating no pain, and '10' worst imaginable pain) that will be used to assess pain intensity. This will be measured as the mean of three pain ratings: best pain rating over 24 hours, worst pain rating over 24 hours, and current pain rating.
Time frame: From enrollment until the end of the study at 12 weeks
Plan to share: Undecided — Requests for deidentified data will be considered on a case by case basis.
No publications or documents are linked to this record.
Ran from Oct 2024 to primary completion in Jul 2025, 8 months.
Of 252 non-industry interventional studies with no phase under Carpal Tunnel Syndrome, half reached primary completion within 12 months of starting (the median), counting those still running; a quarter within 7 and three quarters within 27. This study's 8 months is below that.
Counting every sponsor, half of 262 studies reached it within 12 months; a quarter within 7 and three quarters within 26.
Start moved once since we started tracking on Sep 25, 2026: Nov 2024 → Oct 2024, on Nov 19, 2026.
Earlier changes are on the record history on ClinicalTrials.gov ↗
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is completed, as verified in Feb 2025. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Brooke Army Medical Center